10,000 results · 44ms · Sources: EU EUDAMED, US FDA

SLH 5XC LED DiR - PLATE SYSTEM

Device
EU MDR · Eu Md Class 1 ·Keeler Ltd·On the market·1 country

SLH 5XC LED Di - PLATE SYSTEM

Device
EU MDR · Eu Md Class 1 ·Keeler Ltd·On the market·1 country

SLZ 5XC LED DiR - PLATE SYSTEM

Device
EU MDR · Eu Md Class 1 ·Keeler Ltd·On the market·1 country

SLZ 5XC LED Di - PLATE SYSTEM

Device
EU MDR · Eu Md Class 1 ·Keeler Ltd·On the market·1 country

NIDEK SLH 5XC LED - PLATE SYSTEM

Device
EU MDR · Eu Md Class 1 ·Keeler Ltd·On the market·1 country

Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer

FDA Pre-Market Approval
FDA Class 3 ·ACCESS HYBRITECH PSA REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS

Kit, Test, Alpha-Fetoprotein For Neural Tube Defects

FDA Pre-Market Approval
FDA Class 3 ·ACCESS AFP REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS

Computer-Assisted Personalized Sedation System

FDA Pre-Market Approval
FDA Class 3 ·SEDASYS COMPUTER ASSISTED PERSONALIZED SEDATION SYSTEM

P2psa

FDA Pre-Market Approval
FDA Class 3 ·ACCESS HYBRITECH P2PSA REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS

Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions

FDA Pre-Market Approval
FDA Class 3 ·ACCESS HYBRITECH FREE PSA REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS

QCS HER2 IMMUNOCONTROLS (PRODUCT NO. C010)

FDA 510(k)
FDA Class 2 ·Hematology

SLH 5XC LED Di TBL USA

FDA UDI
KEELER LIMITED·05055272715195·

SLH 5XC 6V TBL 6V LEG

FDA UDI
KEELER LIMITED·05055272711579·

SLH 5XC LED DiR TBL USA

FDA UDI
KEELER LIMITED·05055272715225·

SLH 5XC 12V Di TBL LEG

FDA UDI
KEELER LIMITED·05055272715157·

SLH 5XC LED Di TBL LEG

FDA UDI
KEELER LIMITED·05055272711609·

SLH 5XC LED Di REF ST

FDA UDI
KEELER LIMITED·05055272715164·

Implant, Dermal, For Aesthetic Use

FDA Pre-Market Approval
FDA Class 3 ·JUVEDERM VOLUMA XC

CXC FFT-1 NON-TILT STAT RADIO XRAY TAB 4 WA FL TAB

FDA 510(k)
FDA Class 2 ·Radiology

Drug Coated Prostatic Dilation Catheter For Benign Prostatic Hyperplasia

FDA Pre-Market Approval
FDA Class 3 ·Optilume™ BPH Catheter System